MENU
HOWL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Werewolf Therapeutics (HOWL) Ownership - Who owns Werewolf Therapeutics?
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Profile
Industry
N/A
Address
200 Talcott Avenue
Phone
+1 617 952-0555
Employees
47
Web
https://www.werewolftx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
52.5M
P/E Ratio
N/A
Total Cash
92.04M
Projected Growth
N/A
Total Debt
37.01M
Revenue
1.14M
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
2.05
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
HOWL
Capitalization
52.5M
P/E Ratio
N/A
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash
92M
Total Cash/Share
2.05
Total Debt
37M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
1.14M
ROE
N/A
Book Value
57.3M
P/B Ratio
0.92
Cash Flow
N/A
Earnings
-1.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
8.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-65.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.84
Shares Held By Institutions
29.9M
Shares Outstanding - Current
44.9M
Total Liabilities
49.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-20.946
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HOWL showed earnings on April 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
200 Talcott Avenue
Phone
+1 617 952-0555
Employees
47
Web
https://www.werewolftx.com